Actor SCA (“Actor”) (jointly owned by Triton Fund and KKR) has sold 11,733,902 shares through an accelerated bookbuilding in Ambea. Triton will not reduce its economic exposure to Ambea in connection with the transaction. KKR will be entitled to the sales proceeds in exchange for Triton obtaining a larger economic interest in Actor. Following the transaction KKR will not hold any shares in Ambea.
The transaction was priced at SEK 58 per share and represented 12.4% of the total number of shares in the company.
Following the placing, Actor will continue to own approximately 23.7m shares corresponding to 25.1% of the total number of shares and votes in Ambea.
In line with market practice, Actor has agreed to a lock-up in relation to its remaining shares in Ambea, until the next interim report, which is expected to be published on 19 August 2020.
Carnegie acted Joint Global Co-ordinators and Joint Bookrunners in connection with the transaction.